Iktos

Iktos is an innovative company specialising in the development of artificial intelligence (AI) solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Iktos is developing a proprietary technology platform based on deep learning generative models. The platform enables, using existing data, the design of small molecules, peptides that are optimised in silico to meet all the success criteria of a drug discovery project. The use of Iktos technology platform enables major productivity gains in upstream pharmaceutical R&D. Since its inception, the company has established several collaborations with bio-pharma in Europe and the USA.

Iktos offers its technology both as a professional service and as a SaaS software platform:

Makya™- a ligand and structure-based de novo drug design platform for multi-parametric optimisation (MPO) of lead compounds in line with Target Candidate Profile (TCP).
Spaya™ - a synthesis planning software based upon Iktos’s proprietary AI technology for retrosynthesis.